Look at any country or region with a strong
generic pharmaceutical and active ingredient
manufacturing sector, and you are sure to
see a diverse industry with business models
that range across a spectrum. That spectrum
is typically comprised of ...
Strong forces continue to shape world pharmaceutical markets, most of
which point to continued market share and volume growth for generics.
As global R&D spend stays flat, regulations continue to tighten, user
fees increase and industry ...